Concepedia

Anju Parthan

AP

13

Publications

411

Citations

11

H-Index

2006

Active since

Affiliations

Optum (United States)(Current)

HealthInsight

Amgen (United States)

Harvard University

Marshall B. Ketchum University

Anju Parthan is an author at Optum (United States) specializing in medicine, health policy, and outcomes research.

ORCID

Top concepts

Publications per year

2006–2018

13

Publications

13

Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US

Anju Parthan, Morgan Kruse, Nicole Yurgin et al. · Applied Health Economics and Health Policy · 2013 · 78 citations

, , +8

Comparative Cost-Effectiveness of Stereotactic Body Radiation Therapy Versus Intensity-Modulated and Proton Radiation Therapy for Localized Prostate Cancer

Anju Parthan, Narin Pruttivarasin, D.R.A. Davies et al. · Frontiers in Oncology · 2012 · 68 citations · Full text

Chronic low back pain: epidemiology, economic burden and patient-reported outcomes in the USA

Anju Parthan, Christopher J. Evans, Kim Le · Expert Review of Pharmacoeconomics & Outcomes Research · 2006 · 59 citations

, , +20

Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective

Stuart L. Silverman, Irene Agodoa, Morgan Kruse et al. · Journal of Osteoporosis · 2015 · 33 citations · Full text

, , +23

Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma

Kelly Fust, Xiaoyan Li, Michael Maschio et al. · PharmacoEconomics · 2016 · 33 citations · Full text

Rows per page

1–5 of 13